Tatsuhiko Kodama Selected Research

iminobiotin

1/2022

Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuhiko Kodama Research Topics

Disease

40	Neoplasms (Cancer) 01/2022 - 01/2002
17	Inflammation (Inflammations) 01/2021 - 01/2002
14	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 06/2002
10	COVID-19 05/2022 - 01/2021
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2003
8	Atherosclerosis 01/2019 - 01/2002
8	Hypoxia (Hypoxemia) 04/2014 - 10/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2019 - 06/2006
7	Hepatoblastoma 01/2018 - 10/2005
6	Infections 02/2022 - 07/2004
6	Carcinogenesis 01/2020 - 01/2002
6	Body Weight (Weight, Body) 05/2015 - 12/2008
5	Osteoporosis 03/2014 - 08/2005
4	Down Syndrome Critical Region 01/2021 - 11/2004
4	Down Syndrome (Down's Syndrome) 01/2021 - 11/2004
4	Starvation 10/2019 - 12/2011
4	Leukemia 01/2017 - 07/2007
4	Neoplasm Metastasis (Metastasis) 01/2015 - 08/2013
4	Bone Resorption 03/2014 - 03/2008
4	Obesity 09/2010 - 12/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 02/2002
3	Dyslipidemias (Dyslipidemia) 11/2019 - 01/2018
3	Wilms Tumor (Wilm's Tumor) 01/2018 - 11/2006
3	Arthritis (Polyarthritis) 01/2014 - 11/2006
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2013 - 01/2006
3	Necrosis 11/2012 - 07/2010
3	Insulin Resistance 03/2011 - 12/2003
3	Melanoma (Melanoma, Malignant) 03/2010 - 11/2004
3	Alzheimer Disease (Alzheimer's Disease) 10/2009 - 05/2005
3	Liver Neoplasms (Liver Cancer) 04/2009 - 06/2006
3	Diabetes Mellitus 02/2009 - 01/2003
3	Amyloid Plaque 05/2007 - 09/2004
3	Myocardial Infarction 04/2007 - 01/2004
2	Alcoholic Fatty Liver 01/2022 - 01/2020
2	Hypercholesterolemia 01/2021 - 12/2008

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 05/2022 - 02/2003
10	Immunoglobulin G (IgG)IBA 05/2022 - 01/2015
9	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 09/2003
8	LigandsIBA 01/2022 - 07/2007
8	Pharmaceutical PreparationsIBA 01/2018 - 04/2005
8	LipidsIBA 04/2016 - 10/2002
8	GlypicansIBA 06/2009 - 02/2003
8	oxidized low density lipoproteinIBA 12/2008 - 01/2002
7	AntibodiesIBA 05/2022 - 03/2002
7	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2004
7	AntigensIBA 01/2021 - 12/2005
7	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 10/2005
7	Monoclonal AntibodiesIBA 03/2015 - 03/2005
7	Messenger RNA (mRNA)IBA 11/2013 - 01/2002
7	PTX3 proteinIBA 06/2012 - 01/2007
6	Immunoglobulin M (IgM)IBA 05/2022 - 01/2021
6	CalcineurinIBA 01/2021 - 11/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 11/2004
5	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2022 - 11/2019
5	PPAR alphaIBA 01/2021 - 01/2006
5	Insulin (Novolin)FDA Link 01/2019 - 01/2003
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2010 - 09/2004
5	Scavenger Receptors (Scavenger Receptor)IBA 04/2007 - 01/2002
5	OligonucleotidesIBA 01/2007 - 01/2002
4	ChromatinIBA 01/2022 - 08/2012
4	HDL CholesterolIBA 01/2021 - 09/2010
4	CholesterolIBA 01/2021 - 03/2003
4	Complement System Proteins (Complement)IBA 01/2021 - 06/2006
4	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2003
4	Histone DemethylasesIBA 05/2013 - 08/2009
4	CytokinesIBA 11/2012 - 10/2002
4	Biomarkers (Surrogate Marker)IBA 01/2012 - 04/2004
4	C-Reactive ProteinIBA 01/2012 - 01/2004
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2009 - 04/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2007 - 01/2002
3	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 08/2011
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020 - 07/2006
3	Epidermal Growth Factor (EGF)IBA 01/2016 - 07/2007
3	Histones (Histone)IBA 05/2015 - 01/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015 - 01/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2013 - 01/2002
3	Hypoxia-Inducible Factor 1IBA 06/2013 - 12/2004
3	Small Interfering RNA (siRNA)IBA 12/2011 - 01/2006
3	Hepatocyte Nuclear FactorsIBA 02/2011 - 01/2008
3	MucinsIBA 02/2011 - 05/2005
3	Biological ProductsIBA 01/2011 - 01/2002
3	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 06/2009 - 12/2005
3	Protein Isoforms (Isoforms)IBA 02/2009 - 10/2005
3	LDL Lipoproteins (beta Lipoproteins)IBA 10/2007 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 07/2007 - 02/2004
3	Thrombin FDA Link 07/2006 - 11/2004
2	VaccinesIBA 05/2022 - 03/2022
2	Neutralizing AntibodiesIBA 05/2022 - 01/2016
2	Immunoglobulin A (IgA)IBA 05/2022 - 02/2022
2	Viral ProteinsIBA 02/2022 - 06/2021
2	Nucleocapsid ProteinsIBA 02/2022 - 01/2021
2	AndrogensIBA 01/2022 - 02/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 02/2018
2	MethyltransferasesIBA 06/2021 - 01/2018

Therapy/Procedure

13	Therapeutics 01/2021 - 09/2003
2	Castration 01/2022 - 02/2018
2	Immunotherapy 01/2021 - 01/2014